- Home
- SBRA vs HAE Comparison
SBRA vs HAE Comparison
Compare SBRA & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBRA
- HAE
- Stock Information
- Founded
- SBRA 2010
- HAE 1971
- Country
- SBRA United States
- HAE United States
- Employees
- SBRA N/A
- HAE N/A
- Industry
- SBRA Real Estate Investment Trusts
- HAE Medical/Dental Instruments
- Sector
- SBRA Real Estate
- HAE Health Care
- Exchange
- SBRA Nasdaq
- HAE Nasdaq
- Market Cap
- SBRA 4.3B
- HAE 3.8B
- IPO Year
- SBRA N/A
- HAE 1991
- Fundamental
- Price
- SBRA $18.41
- HAE $85.57
- Analyst Decision
- SBRA Strong Buy
- HAE Strong Buy
- Analyst Count
- SBRA 6
- HAE 8
- Target Price
- SBRA $19.00
- HAE $107.88
- AVG Volume (30 Days)
- SBRA 2.3M
- HAE 760.7K
- Earning Date
- SBRA 10-31-2024
- HAE 11-07-2024
- Dividend Yield
- SBRA 6.52%
- HAE N/A
- EPS Growth
- SBRA N/A
- HAE N/A
- EPS
- SBRA 0.41
- HAE 2.41
- Revenue
- SBRA $682,324,000.00
- HAE $1,361,223,000.00
- Revenue This Year
- SBRA N/A
- HAE $7.71
- Revenue Next Year
- SBRA $5.19
- HAE $4.89
- P/E Ratio
- SBRA $45.11
- HAE $35.50
- Revenue Growth
- SBRA 20.53
- HAE 9.84
- 52 Week Low
- SBRA $12.83
- HAE $70.25
- 52 Week High
- SBRA $20.03
- HAE $97.97
- Technical
- Relative Strength Index (RSI)
- SBRA 46.53
- HAE 57.73
- Support Level
- SBRA $18.16
- HAE $83.32
- Resistance Level
- SBRA $18.62
- HAE $86.68
- Average True Range (ATR)
- SBRA 0.51
- HAE 2.65
- MACD
- SBRA -0.10
- HAE -0.15
- Stochastic Oscillator
- SBRA 20.98
- HAE 56.73
About SBRA Sabra Health Care REIT Inc.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.